Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Author:

Brooks JenniferORCID,Nabi Hermann,Andrulis IreneORCID,Antoniou Antonis,Chiquette Jocelyne,Després PhilippeORCID,Devilee PeterORCID,Dorval MichelORCID,Droit ArnaudORCID,Easton Douglas,Eisen Andrea,Eloy Laurence,Fienberg Samantha,Goldgar David,Hahnen Eric,Joly Yann,Knoppers BarthaORCID,Lofters Aisha,Masson Jean-Yves,Mittmann Nicole,Paquette Jean-SébastienORCID,Pashayan NoraORCID,Schmutzler Rita,Stockley TracyORCID,Tavtigian Sean,Walker Meghan,Wolfson Michael,Chiarelli Anna,Simard Jacques

Abstract

Early detection of breast cancer through screening reduces breast cancer mortality. The benefits of screening must also be considered within the context of potential harms (e.g., false positives, overdiagnosis). Furthermore, while breast cancer risk is highly variable within the population, most screening programs use age to determine eligibility. A risk-based approach is expected to improve the benefit-harm ratio of breast cancer screening programs. The PERSPECTIVE I&I (Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation) project seeks to improve personalized risk assessment to allow for a cost-effective, population-based approach to risk-based screening and determine best practices for implementation in Canada. This commentary describes the four inter-related activities that comprise the PERSPECTIVE I&I project. 1: Identification and validation of novel moderate to high-risk susceptibility genes. 2: Improvement, validation, and adaptation of a risk prediction web-tool for the Canadian context. 3: Development and piloting of a socio-ethical framework to support implementation of risk-based breast cancer screening. 4: Economic analysis to optimize the implementation of risk-based screening. Risk-based screening and prevention is expected to benefit all women, empowering them to work with their healthcare provider to make informed decisions about screening and prevention.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference88 articles.

1. Canadian Cancer Statistics Advisory Committee Canadian Cancer Statistics 2019 http://cancer.ca/Canadian-Cancer-Statistics-2019-EN

2. Guidelines for the Economic Evaluation of Health Technologies: Canada https://www.cadth.ca/about-cadth/how-we-do-it/methods-and-guidelines/guidelines-for-the-economic-evaluation-of-health-technologies-canada

3. Phase-specific and lifetime costs of cancer care in Ontario, Canada

4. Economic cost of chronic disease in Canada https://www.ocdpa.ca/sites/default/files/publications/OCDPA_EconomicCosts.pdf

5. Estimates of the lifetime costs of breast cancer treatment in Canada

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3